ClinicalTrials.gg
CompletedNCT07194434Updated Sep 26, 2025

The Impact of War-Related Pollution on Public Health: Identifying Associated Health Conditions in Conflict Zones, Sudan 2025

An observational study in Pollution and Armed Conflicts Pollution, sponsored by Research and Publication office. Completed at 1 site in Sudan. Per ClinicalTrials.gov, last updated 2025-09-26.

Sponsored by Research and Publication office · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
399
Sex
All
01

Study summary

This study aims to investigate the impact of war-related pollution on public health in affected areas. It will address the types of pollutants, the prevalence of pollution-related health conditions, and risk factors. The study will also assess the relationship between pollution and health outcomes, the severity of long-term effects, healthcare availability, public awareness of pollution's health impact, and current efforts to mitigate its harmful effects.

Read the detailed description

This study aims to explore the impact of war-related pollution on public health by identifying associated health conditions in conflict-affected areas. The research will focus on the types and sources of pollutants, the prevalence of health issues linked to pollution exposure, and the factors that increase health risks. It will also assess the relationship between specific pollutants and health outcomes, the severity of these impacts, and the availability of healthcare services. Furthermore, the study will evaluate public awareness of pollution's health effects and ongoing efforts to mitigate its adverse consequences.

02

Conditions studied

  • Pollution
  • Armed Conflicts Pollution

Keywords

  • Pollution
  • Armed conflicts
  • Sudan
  • War
03

In context

Lead sponsor

Research and Publication office is the lead sponsor of 5 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Displaced adults living in conflict zones in Sudan.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults
  • Displaced
  • Living in conflict zone
  • Consented to participate

Exclusion criteria

Exclusion Criteria:

  • Non adults
  • Residents of A non conflict zone area
  • Not consenting to participate.
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
399 participants (actual)
Patient registry
No

Groups and cohorts

  • Conflict zones residents

    Conflict zones residents

    Other: No.intervrntion

Interventions

  • OtherNo.intervrntion

    No intervention

06

What researchers measure

Primary outcomes

  1. To identify the the impact of war-related pollution on public health

    Time frame: Jan - Mar 2025

Secondary outcomes

  1. To measure the frequency of health conditions linked to war-related pollution

    Time frame: Jan - Mar 2025

  2. To identify the types and sources of pollutants

    Time frame: Jan - Mar 2025

  3. To determine the factors that increase susceptibility to health issues caused by pollution exposure.

    Time frame: Jan - Mar 2025

  4. To evaluate the long-term health outcomes and severity of pollution-related conditions

    Time frame: Jan- Mar 2025

07

Study locations

1 site
  • Research and publication office
    Khartoum, Omdurman 11111, Sudan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2025 to primary completion in Mar 2025, 1 month.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 10, 2025
First posted
Sep 26, 2025
StartActual
Jan 22, 2025
Primary completionActual
Mar 12, 2025
CompletionActual
Mar 12, 2025
Last update
Sep 26, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 26, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07194434
Lead sponsor
Research and Publication office
Responsible party
Sponsor
First posted
Sep 26, 2025
Start date
Jan 22, 2025
Primary completion
Mar 12, 2025
Completion
Mar 12, 2025
Last update
Sep 26, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion